Trial Details

COMPLETED
Basic Information
Clinical ID c4423
Identifier NCT00552344
Trial Title A Study to Evaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Crohn Disease
Interventions BIOLOGICAL: Cimzia
Participant Information
Sponsor UCB BIOSCIENCES GmbH
City Lakewood
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2008-05
Primary Completion Date 2014-12
Completion Date 2014-12